Dopaminergic agonists in the treatment of Parkinson's disease: a review.


Dopaminergic agonists represent an important class of drugs in Parkinson's Disease, useful: a) in delaying the beginning of L-dopa therapy; b) in supporting it, reducing its dosage and widen the therapeutic window; c) moreover, as the disease advances, in trying to treat motor fluctuations. Authors describe briefly the problems caused by long term L-dopa therapy, and analyze, separately, the characteristics of the most important dopaminergic agonists currently utilized in the treatment of PD.


Citations per Year

168 Citations

Semantic Scholar estimates that this publication has 168 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Piccoli1995DopaminergicAI, title={Dopaminergic agonists in the treatment of Parkinson's disease: a review.}, author={Fabiana Piccoli and R M Riuggeri}, journal={Journal of neural transmission. Supplementum}, year={1995}, volume={45}, pages={187-95} }